Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients

Mikael Koponen, Aki S. Havulinna, Annukka Marjamaa, Annukka M. Tuiskula, Veikko Salomaa, Päivi J. Laitinen-Forsblom, Kirsi Piippo, Lauri Toivonen, Kimmo Kontula, Matti Viitasalo, Heikki Swan

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number56
JournalBMC Medical Genetics
Volume19
Number of pages10
ISSN1471-2350
DOIs
Publication statusPublished - 5 Apr 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Long QT syndrome
  • Cardiac arrhythmia
  • Risk stratification
  • beta-blocker
  • Implantable cardioverter-defibrillator
  • IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
  • MUTATION-SPECIFIC RISK
  • CARDIAC EVENTS
  • BETA-BLOCKERS
  • STRATIFICATION
  • GENOTYPE
  • MANAGEMENT
  • IDENTIFICATION
  • ARRHYTHMIAS
  • EFFICACY
  • 3111 Biomedicine

Cite this